TECLens Overview

  • Founded
  • 2013

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $200K

TECLens General Information


Developer of a non-invasive single treatment therapy designed to address the problem of Myopia. The company's therapy is assisted by Corneal Crosslinking Lens that is comfortable and may be worn with the eye open or closed and has a real-time ultrasound sensing for accurate prescription tuning, enabling eye specialists to assure Myopia treatment in a faster, secure and cost effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 9 Riverbend Drive South
  • Stamford, CT 06907
  • United States
+1 (631) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TECLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 06-Feb-2019 $200K 00.000 Completed Startup
2. Seed Round 02-Jun-2017 00.000 00.000 Completed Startup
1. Angel (individual) 01-Jan-2014 Completed Startup
To view TECLens’s complete valuation and funding history, request access »

TECLens Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a non-invasive single treatment therapy designed to address the problem of Myopia. The company's therapy is
Therapeutic Devices
Stamford, CT
0000000000 00.000


exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
00000000000 0000000
San Diego, CA
0 As of 0000
00.00 0000-00-00
00000000000 00.00


lit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sun
00000000000 0000000
Yokneam, Israel
0000 As of 0000
0.00 0000-00-00
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TECLens Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Yolia Health Venture Capital-Backed San Diego, CA 0 00.00 00000000000 00.00
0000000 Private Equity-Backed Yokneam, Israel 0000 00000 000000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

TECLens Patents

TECLens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200353279-A1 Corneal crosslinking with catalyst distribution control Pending 28-Mar-2019 0000000000
US-20180356588-A1 Light scattering fiber and devices incorporating same Abandoned 13-Jun-2017 00000000000
EP-3689249-A1 Corneal measurement and control of corneal crosslinking Withdrawn 29-Feb-2016 000000000
EP-3422954-B1 Corneal measurement and control of corneal crosslinking Active 29-Feb-2016 000000000
US-11020608-B2 Corneal measurement and control of corneal crosslinking Active 29-Feb-2016 A61N5/062
To view TECLens’s complete patent history, request access »

TECLens Executive Team (4)

Name Title Board Seat Contact Info
David Acker Co-Founder & Chief Executive Officer
Patrick Lopath Co-Founder & Chief Operating Officer
Frances Chen Executive Vice President, Business Development
Roy Chuck Ph.D Co-Founder & Chairman
To view TECLens’s complete executive team members history, request access »

TECLens Board Members (1)

Name Representing Role Since
Roy Chuck Ph.D TECLens Co-Founder & Chairman 000 0000
To view TECLens’s complete board members history, request access »